Listed as “insitro”
- First observed:
- 30 Oct 2026
- Investment announced:
- Date not recorded
insitro brings together life scientists, data scientists, engineers, and drug hunters to design experiments and build models.
insitro’s culture unites life scientists, data scientists, engineers, and drug hunters to identify key questions, design and scale experiments, and analyze results. The company applies machine learning and large‑scale data to decode biological complexity and develop new medicines for patients.
Bio + Health
Category source ↗Checked
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “insitro”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.